Wockhardt
Clinical trials sponsored by Wockhardt, explained in plain language.
-
New antibiotic duo takes on tough UTIs in head-to-head trial
Disease control CompletedThis study tested a new antibiotic called cefepime-zidebactam against a standard antibiotic (meropenem) in about 530 adults hospitalized with complicated urinary tract infections or kidney infections. The goal was to see if the new drug works as well and is safe. Participants rec…
Phase: PHASE3 • Sponsor: Wockhardt • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New antibiotic combo passes early safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes a new antibiotic combination (Zidebactam-Cefepime) when given alone or with another antibiotic (metronidazole). Thirty healthy adults each received three different single-dose treatments in a crossover design. Th…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated May 17, 2026 06:52 UTC
-
Healthy men help scientists track new Antibiotic's journey through the body
Knowledge-focused CompletedThis study looked at how healthy men break down and get rid of the experimental antibiotic zidebactam. Eight participants received a single dose with a radioactive tag to track where the drug goes. The goal was to measure how much leaves the body in urine and stool, and to identi…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Healthy volunteers test new antibiotic for safety
Knowledge-focused CompletedThis early-stage study tested an experimental antibiotic called zidebactam in 21 healthy adults. The goal was to check if multiple doses given through a vein are safe and how the body processes the drug. No treatment was given for any disease, so this study helps gather basic saf…
Phase: PHASE1 • Sponsor: Wockhardt • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC